135 related articles for article (PubMed ID: 32763535)
1. Treatment of double depression: A meta-analysis.
May DG; Shaffer VN; Yoon KL
Psychiatry Res; 2020 Sep; 291():113262. PubMed ID: 32763535
[TBL] [Abstract][Full Text] [Related]
2. Treatment of major depressive disorder and dysthymic disorder with antidepressants in patients with comorbid opiate use disorders enrolled in methadone maintenance therapy: a meta-analysis.
Pedrelli P; Iovieno N; Vitali M; Tedeschini E; Bentley KH; Papakostas GI
J Clin Psychopharmacol; 2011 Oct; 31(5):582-6. PubMed ID: 21869696
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
Levkovitz Y; Tedeschini E; Papakostas GI
J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
5. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
6. The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression.
Rhebergen D; Beekman AT; Graaf Rd; Nolen WA; Spijker J; Hoogendijk WJ; Penninx BW
J Affect Disord; 2009 Jun; 115(3):450-9. PubMed ID: 19042028
[TBL] [Abstract][Full Text] [Related]
7. Managing antidepressants in primary care: physicians' treatment modifications.
Tamburrino MB; Nagel RW; Lynch DJ
Psychol Rep; 2011 Jun; 108(3):799-804. PubMed ID: 21879626
[TBL] [Abstract][Full Text] [Related]
8. Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction.
McCullough JP; Klein DN; Keller MB; Holzer CE; Davis SM; Kornstein SG; Howland RH; Thase ME; Harrison WM
J Abnorm Psychol; 2000 Aug; 109(3):419-27. PubMed ID: 11016111
[TBL] [Abstract][Full Text] [Related]
9. Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy.
Pinquart M; Duberstein PR; Lyness JM
Am J Psychiatry; 2006 Sep; 163(9):1493-501. PubMed ID: 16946172
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.
MacQueen G; Santaguida P; Keshavarz H; Jaworska N; Levine M; Beyene J; Raina P
Can J Psychiatry; 2017 Jan; 62(1):11-23. PubMed ID: 27554483
[TBL] [Abstract][Full Text] [Related]
11. The Korean Medication Algorithm for Depressive Disorder: second revision.
Seok Seo J; Rim Song H; Bin Lee H; Park YM; Hong JW; Kim W; Wang HR; Lim ES; Jeong JH; Jon DI; Joon Min K; Sup Woo Y; Bahk WM
J Affect Disord; 2014; 167():312-21. PubMed ID: 25010375
[TBL] [Abstract][Full Text] [Related]
12. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.
Browne G; Steiner M; Roberts J; Gafni A; Byrne C; Dunn E; Bell B; Mills M; Chalklin L; Wallik D; Kraemer J
J Affect Disord; 2002 Apr; 68(2-3):317-30. PubMed ID: 12063159
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the treatment of dysthymia: a narrative review.
Mathias L; Quagliato LA; Carta MG; Nardi AE; Cheniaux E
Expert Rev Neurother; 2024 Jul; 24(7):633-642. PubMed ID: 38805342
[TBL] [Abstract][Full Text] [Related]
15. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis.
Cuijpers P; Dekker J; Hollon SD; Andersson G
J Clin Psychiatry; 2009 Sep; 70(9):1219-29. PubMed ID: 19818243
[TBL] [Abstract][Full Text] [Related]
16. Trajectories of recovery of social and physical functioning in major depression, dysthymic disorder and double depression: a 3-year follow-up.
Rhebergen D; Beekman AT; de Graaf R; Nolen WA; Spijker J; Hoogendijk WJ; Penninx BW
J Affect Disord; 2010 Jul; 124(1-2):148-56. PubMed ID: 19945171
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell cytotoxity and course of illness in depressed mood.
Reynaert C; Janne P; Jacques D; Tordeurs D; Zdanowicz N
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S132-4. PubMed ID: 21057421
[TBL] [Abstract][Full Text] [Related]
18. Review of dysthymia and persistent depressive disorder: history, correlates, and clinical implications.
Schramm E; Klein DN; Elsaesser M; Furukawa TA; Domschke K
Lancet Psychiatry; 2020 Sep; 7(9):801-812. PubMed ID: 32828168
[TBL] [Abstract][Full Text] [Related]
19. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI; Martinson MA; Fava M; Iovieno N
J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
[TBL] [Abstract][Full Text] [Related]
20. The categorisation of dysthymic disorder: can its constituents be meaningfully apportioned?
Rhebergen D; Graham R; Hadzi-Pavlovic D; Stek M; Friend P; Barrett M; Parker G
J Affect Disord; 2012 Dec; 143(1-3):179-86. PubMed ID: 22835850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
